{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:45:21Z","timestamp":1781577921709,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":214,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ebr.2024.100703","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T18:10:53Z","timestamp":1723140653000},"page":"100703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Opercular myoclonic-anarthric status (OMASE) secondary to anti-Hu paraneoplastic neurological syndrome"],"prefix":"10.1016","volume":"27","author":[{"given":"C\u00e9sar","family":"Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"Quijada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Abudin\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ledda","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebr.2024.100703_b0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1528-1157.1995.tb00997.x","article-title":"Opercular myoclonic-anarthric status epilepticus","volume":"36","author":"Thomas","year":"1995","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ebr.2024.100703_b0010","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/jnnp.2005.085282","article-title":"Opercular syndrome due to non-convulsive status epilepticus in an adult","volume":"77","author":"Steiner-Birmanns","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ebr.2024.100703_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jnnp.73.2.203","article-title":"Slowly progressive Foix-Chavany-Marie syndrome associated with chronic herpes simplex encephalitis","volume":"73","author":"Sasaguri","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ebr.2024.100703_b0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1684\/epd.2013.0596","article-title":"Opercular myoclonic-anarthric status epilepticus due to glutamic acid decarboxylase antibody-associated encephalitis","volume":"15","author":"Monnerat","year":"2013","journal-title":"Epileptic Disord"},{"issue":"10","key":"10.1016\/j.ebr.2024.100703_b0025","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1528-1157.1995.tb00965.x","article-title":"Acquired epileptiform opercular syndrome: a second case report, review of the literature, and comparison to the Landau-Kleffner syndrome","volume":"36","author":"Shafrir","year":"1995","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ebr.2024.100703_b0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4103\/0972-2327.120470","article-title":"Opercular myoclonic-anarthric status epilepticus: a report of two cases","volume":"16","author":"Bhaskara Rao","year":"2013","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"10.1016\/j.ebr.2024.100703_b0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurology - Neuroimmunol Neuroinflamm"},{"issue":"Pt 6","key":"10.1016\/j.ebr.2024.100703_b0040","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ebr.2024.100703_b0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","article-title":"Anti-Hu-associated brainstem encephalitis","volume":"80","author":"Saiz","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.ebr.2024.100703_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2010.10.009","article-title":"Onconeural antibodies: improved detection and clinical correlations","volume":"232","author":"Storstein","year":"2011","journal-title":"J Neuroimmunol."},{"issue":"2","key":"10.1016\/j.ebr.2024.100703_b0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/1531-8249(199902)45:2<255::AID-ANA18>3.0.CO;2-N","article-title":"Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"45","author":"Shavit","year":"1999","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ebr.2024.100703_b0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(03)00130-8","article-title":"Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome","volume":"213","author":"Jacobs","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebr.2024.100703_b0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pediatrneurol.2016.08.024","article-title":"Antineuronal nuclear autoantibody type 1\/anti-Hu\u2013associated opsoclonus myoclonus and epilepsia partialis continua: case report and literature review","volume":"65","author":"Sweeney","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1016\/j.ebr.2024.100703_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102388","article-title":"Focal status epilepticus in anti-Hu encephalitis","volume":"18","author":"Frazzini","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.ebr.2024.100703_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1535759720949238","article-title":"How much GAD65 do you have? High levels of GAD65 antibodies in autoimmune encephalitis","volume":"20","author":"Gaspard","year":"2020","journal-title":"Epilepsy Curr."},{"issue":"1","key":"10.1016\/j.ebr.2024.100703_b0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.71.1.100","article-title":"Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases","volume":"71","author":"Meinck","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 10","key":"10.1016\/j.ebr.2024.100703_b0085","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain."},{"issue":"4","key":"10.1016\/j.ebr.2024.100703_b0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ebr.2024.100703_b0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebr.2024.100703_b0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies","volume":"92","author":"Budhram","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Epilepsy &amp; Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T13:57:04Z","timestamp":1724853424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986424000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"alternative-id":["S2589986424000601"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100703","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opercular myoclonic-anarthric status (OMASE) secondary to anti-Hu paraneoplastic neurological syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100703"}}